Biomarkers of Mucinous Tumors of the Ovary

Por Goli Samimi, Laurent Ozbun, Michael E. Johnson, Samuel C. Mok, Michael J. Birrer
Publicado em 2007-01-01

Etiology and Pathogenesis of Epithelial Ovarian Cancer

Por Samuel C. Mok, Joseph Kwong, William R. Welch, Goli Samimi, Laurent Ozbun, Tomas Bonome, Michael J. Birrer, Ross S. Berkowitz, Kwong-Kwok Wong
Publicado em 2007-01-01

Overexpression of Elafin in Ovarian Carcinoma Is Driven by Genomic Gains and Activation of the Nuclear Factor κB Pathway and Is Associated with Poor Overall Survival

Por Adam Clauss, Vivian Ng, Joyce Liu, Huiying Piao, Moises Russo, Natalie Vena, Qing Sheng, Michelle S. Hirsch, Tomas Bonome, Ursula Matulonis, Azra H. Ligon, Michael J. Birrer, Ronny Drapkin
Publicado em 2010-02-01

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncolo...

Por Alessandro D. Santin, Virginia Filiaci, Stefania Bellone, Elena S. Ratner, Cara A. Mathews, Guilherme Cantuaria, Camille C. Gunderson, Teresa Rutledge, Barbara M. Buttin, Heather A. Lankes, Michael Frumovitz, Samir N. Khleif, Warner K. Huh, Michael J. Birrer
Publicado em 2020-02-01

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.

Por Christopher K McCann, Whitfield B Growdon, Kashmira Kulkarni-Datar, Michael D Curley, Anne M Friel, Jennifer L Proctor, Hana Sheikh, Igor Deyneko, Jeanne A Ferguson, Vinod Vathipadiekal, Michael J Birrer, Darrell R Borger, Gayatry Mohapatra, Lawrence R Zukerberg, Rosemary Foster, John R Macdougall, Bo R Rueda
Publicado em 2011-01-01